Cargando…
Stimulated Bronchial Epithelial Cells Release Bioactive Lysophosphatidylcholine 16:0, 18:0, and 18:1
PURPOSE: In human subjects and animal models with acute and chronic lung injury, the bioactive lysophosphatidylcholine (LPC) is elevated in lung lining fluids. The increased LPC can promote an inflammatory microenvironment resulting in lung injury. Furthermore, pathological lung conditions are assoc...
Autores principales: | Zhuge, Yan, Yuan, Yang, van Breemen, Richard, DeGrand, Michael, Holian, Oksana, Yoder, Mark, Lum, Hazel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881404/ https://www.ncbi.nlm.nih.gov/pubmed/24404396 http://dx.doi.org/10.4168/aair.2014.6.1.66 |
Ejemplares similares
-
Bioactive Lysophosphatidylcholine 16:0 and 18:0 Are Elevated in Lungs of Asthmatic Subjects
por: Yoder, Mark, et al.
Publicado: (2014) -
Elevated 18:0 lysophosphatidylcholine contributes to the development of pain in tissue injury
por: Friston, Dominic Anthony, et al.
Publicado: (2023) -
Increased Expression of Phosphatidylcholine (16:0/18:1) and (16:0/18:2) in Thyroid Papillary Cancer
por: Ishikawa, Seiji, et al.
Publicado: (2012) -
Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study
por: Kühn, Tilman, et al.
Publicado: (2016) -
Differential levels of L-homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer
por: KIM, SEUNG CHEOL, et al.
Publicado: (2014)